Contact Us

Mass Spec Protein Assays in FFPE Tissue

We are advancing personalized medicine with non-antibody protein assays that measure functional cancer signaling networks in FFPE tissue to individualize and improve patient treatment decisions.

           Expression Pathology provides Roche SRM Protein Biomarker Assay Services        Biomarker Summit 2012        ABRF 2012 Tissue Proteomic Workshop

Pharma Collaborations

Our broad menu of multiplexed Liquid Tissue®-SRM assays for major cancer signaling networks can advance development of targeted therapies and improve patient stratification needs. (More...)

Clinical Applications

We are developing a CLIA certified facility to offer proprietary Liquid Tissue®-SRM molecular pathology tests that may improve evaluation of tumors and patient selection for targeted drugs, with EGFR and IGF-1R as the initial focus. (More...)

Technology

Our patented Liquid Tissue®-SRM technology platform makes possible highly multiplexed quantitation by powerful mass spectrometry of minute amounts of laser microdissected FFPE tissue. (More...)